Anchor Capital Advisors’s Viemed Healthcare VMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-33,078
Closed -$223K 264
2023
Q3
$223K Hold
33,078
0.01% 256
2023
Q2
$324K Sell
33,078
-27,127
-45% -$275K 0.01% 235
2023
Q1
$582K Sell
60,205
-148,466
-71% -$1.29M 0.02% 209
2022
Q4
$1.58M Sell
208,671
-1,355
-0.6% -$9.18K 0.04% 143
2022
Q3
$1.26M Sell
210,026
-515
-0.2% -$3.31K 0.03% 150
2022
Q2
$1.13M Sell
210,541
-1,125
-0.5% -$6.06K 0.03% 169
2022
Q1
$1.05M Buy
211,666
+51,580
+32% +$240K 0.02% 187
2021
Q4
$836K Sell
160,086
-18,365
-10% -$102K 0.02% 194
2021
Q3
$990K Sell
178,451
-216,123
-55% -$1.41M 0.02% 183
2021
Q2
$2.82M Buy
394,574
+3,882
+1% +$33.6K 0.06% 133
2021
Q1
$3.95M Buy
+390,692
New +$3.68M 0.08% 115

Other funds holding VMD

Anchor Capital Advisors's VMD Position: Q4 2023 in Review

Anchor Capital Advisors sold out of Viemed Healthcare (VMD) in Q4 2023, closing a stake of 33,078 shares — an estimated $223K sold.

Anchor Capital Advisors first reported a position in VMD in Q1 2021 and held it in 11 quarters. The position peaked at $3.95M in Q1 2021. 104 funds tracked by Wall St. Rank hold VMD as of Q4 2023.

  • Anchor Capital Advisors reported no remaining Viemed Healthcare position as of Q4 2023 after selling out during the quarter.
  • Anchor Capital Advisors sold 33,078 Viemed Healthcare shares in Q4 2023, an estimated $223K.
  • Anchor Capital Advisors first reported a position in Viemed Healthcare in Q1 2021 and held it in 11 quarters.
  • Anchor Capital Advisors's Viemed Healthcare position peaked at $3.95M in Q1 2021.
  • 104 funds tracked by Wall St. Rank held Viemed Healthcare as of Q4 2023.

Based on Anchor Capital Advisors's 13F filing for Q4 2023, filed 5 Feb 2024.